Aviation Medication Transparency Act of 2025

This legislation mandates that the Administrator of the Federal Aviation Administration (FAA) compile, publish, and continuously maintain a publicly available, comprehensive list of medications and treatments pertinent to the medical certification of airmen. This list must be made accessible on the FAA's website within one year of the Act's enactment and updated annually thereafter, aiming to enhance transparency for airmen and medical professionals. Its development requires extensive consultation with key stakeholders, including the Aeromedical Innovation and Modernization Working Group , representatives of air traffic controllers, and the largest certified collective bargaining representative of airline pilots, ensuring a broad range of expertise. The list is designed to be user-friendly and accessible , providing airmen with crucial information when they first seek a license and medical certification, and will include a mechanism for doctors to contact the FAA with questions. Key requirements for the list include detailing medications that may be safely prescribed for certain conditions, indicating the average stabilization period an airman must observe for an approved medication, and explicitly listing those designated as "Do Not Issue." Additionally, the list must provide explanations for why a medication is allowed or prohibited by the FAA, offering comprehensive guidance and clarification on medical eligibility.